1073485-64-9

Upstream product

• 1159281-95-4 N-[2-(tert-butyldiphenyl-silanyloxy)ethyl]-C-(3-nitrophenyl)methanesulfonamide 
• 58032-84-1 (3-nitrophenyl)methanesulfonyl chloride 
• 1159281-96-5 C-(3-aminophenyl)-N-[2-(tert-butyldiphenylsilanyloxy)-ethyl]methanesulfonamide 

Downstream Products

• 1159281-94-3 N-(2-hydroxyethyl)-C-[3-(2,4,6-trichlorophenylamino)phenyl]methane sulphonamide 

Relevant academic research and scientific papers

POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF

Compounds of formula (I) and pharmacologically acceptable salts and pro-drugs wherein: Ar1 and Ar2=aryl or heteroaryl; a=0 to 5; R1=alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, hydroxyl, amino, monalkylamin

POTASSIUM ION CHANNEL MODULATORS and USES THEREOF

Compounds of formula (I) and pharmacologically acceptable salts and pro- drugs wherein: Ar1 and Ar 2 =aryl orheteroaryl; a = 0 to 5; R1 =alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, hydroxyl, amino, monalky

4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES

The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.